Newswise News from Mizuho OSI Latest news from Mizuho OSI on Newswise en-us Copyright 2024 Newswise Newswise News from Mizuho OSI 115 31 / /images/newswise-logo-rss.gif Mizuho OSI Named Recipient of Advanced Manufacturing Award /articles/mizuho-osi-named-recipient-of-advanced-manufacturing-award/?sc=rsin /articles/mizuho-osi-named-recipient-of-advanced-manufacturing-award/?sc=rsin Thu, 22 Oct 2020 14:50:35 EST Union City, Calif. - October 19, 2020 - Mizuho OSI, the pioneer of orthopedic surgical tables and pressure management solutions, was named the recipient of the Advanced Manufacturing award during the 8th Annual East Bay Innovation Awards virtual presentation on October 15. Mizuho OSI Mizuho OSI(r) Acquires the Nimbic Air Barrier System to Expand into Helping Protect Surgical Sites from Airborne Particulates /articles/mizuho-osi-acquires-the-nimbic-air-barrier-system-to-expand-into-helping-protect-surgical-sites-from-airborne-particulates/?sc=rsin /articles/mizuho-osi-acquires-the-nimbic-air-barrier-system-to-expand-into-helping-protect-surgical-sites-from-airborne-particulates/?sc=rsin Tue, 08 Sep 2020 08:00:01 EST Mizuho OSI(r), a leading manufacturer of specialty surgical tables and pressure injury abatement solutions is pleased to announce the acquisition of the Air Barrier System (ABS) from Nimbic Systems, Inc. Mizuho OSI Clinical Utility of Hana(r) Orthopedic Table Highlighted in New Study: 97% of Direct Anterior Approach Hip Replacement Patients Needed Little to No Opioid Pain Medication After Surgery /articles/clinical-utility-of-hana-orthopedic-table-highlighted-in-new-study-97-of-direct-anterior-approach-hip-replacement-patients-needed-little-to-no-opioid-pain-medication-after-surgery/?sc=rsin /articles/clinical-utility-of-hana-orthopedic-table-highlighted-in-new-study-97-of-direct-anterior-approach-hip-replacement-patients-needed-little-to-no-opioid-pain-medication-after-surgery/?sc=rsin Mon, 24 Aug 2020 11:00:15 EST Mizuho OSI(r), a leading manufacturer of specialty surgical tables and pressure injury abatement solutions would like to announce the publication of a new clinical study titled "23-hour Total Hip Replacement Requiring Only 3.5 Opioid Pills Through 6 Weeks: A Non-selected Prospective Consecutive One Year Cohort", by Andrew Wickline MD, now appearing in the peer-reviewed Journal of Orthopedic Experience & Innovation (JournalOEI) Mizuho OSI